The invention provides compounds of Formula (I):
1
wherein: R
1
-R
5
, A, L, and X have any of the values defined in the specification that are CCR-3 receptor antagonists, pharmaceutical compositions containing them, methods for their use, and methods and intermediates useful for preparing them.